Peter Greenleaf, Aurinia Pharmaceuticals CEO

Au­rinia fails to find buy­er, will shed pipeline to fo­cus on Lup­ky­nis

Au­rinia Phar­ma­ceu­ti­cals said it was un­able to at­tract any for­mal of­fers dur­ing its strate­gic re­view process, which be­gan last sum­mer af­ter

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.